180 related articles for article (PubMed ID: 25492487)
1. Serum adiponectin levels may be associated with the pathogenesis of hepatocellular carcinoma.
Song RR; Gu XL
Tumour Biol; 2015 Apr; 36(4):2983-92. PubMed ID: 25492487
[TBL] [Abstract][Full Text] [Related]
2. Manganese levels and hepatocellular carcinoma: A systematic review and meta-analysis based on Asian cohort.
Chen XB; Wei YH; Chen XK; Zhong J; Zou YB; Nie JY
Medicine (Baltimore); 2019 Aug; 98(32):e16748. PubMed ID: 31393389
[TBL] [Abstract][Full Text] [Related]
3. The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis.
Zhang L; Yuan Q; Li M; Chai D; Deng W; Wang W
BMC Cancer; 2020 Nov; 20(1):1167. PubMed ID: 33256658
[TBL] [Abstract][Full Text] [Related]
4. Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk.
Li HG; Liu FF; Zhu HQ; Zhou X; Lu J; Chang H; Hu JH
Medicine (Baltimore); 2015 Nov; 94(47):e2019. PubMed ID: 26632699
[TBL] [Abstract][Full Text] [Related]
5. Serum adiponectin levels are inversely correlated with leukemia: A meta-analysis.
Ma JJ; Shang J; Wang H; Sui JR; Liu K; Du JX
J Cancer Res Ther; 2016; 12(2):897-902. PubMed ID: 27461671
[TBL] [Abstract][Full Text] [Related]
6. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
Li YS; Xie Q; Yang DY; Zheng Y
Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
[TBL] [Abstract][Full Text] [Related]
7. Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.
Sumie S; Kawaguchi T; Kuromatsu R; Takata A; Nakano M; Satani M; Yamada S; Niizeki T; Torimura T; Sata M
PLoS One; 2011; 6(11):e26840. PubMed ID: 22110596
[TBL] [Abstract][Full Text] [Related]
8. Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
Shen J; Yeh CC; Wang Q; Gurvich I; Siegel AB; Santella RM
Anticancer Res; 2016 Oct; 36(10):5307-5314. PubMed ID: 27798893
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
Lee YH; Song GG
Z Rheumatol; 2017 Nov; 76(9):789-797. PubMed ID: 27515182
[TBL] [Abstract][Full Text] [Related]
10. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
11. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis.
Qin H; Liu B; Shi T; Liu Y; Sun Y; Ma Y
J Int Med Res; 2010; 38(3):760-8. PubMed ID: 20819413
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
[TBL] [Abstract][Full Text] [Related]
14. The promoting effect of adiponectin in hepatocellular carcinoma.
Chen MJ; Yeh YT; Lee KT; Tsai CJ; Lee HH; Wang SN
J Surg Oncol; 2012 Aug; 106(2):181-7. PubMed ID: 22287480
[TBL] [Abstract][Full Text] [Related]
15. Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population.
Liu Y; Huang L; Lu Y; Xi XE; Huang XL; Lu Q; Huang X; Li S; Qin X
PLoS One; 2015; 10(1):e0116479. PubMed ID: 25587715
[TBL] [Abstract][Full Text] [Related]
16. Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Yu BW; Zhang LQ; Teng XL; Zhang Y; Zou LB; Ying HY
Genet Mol Res; 2015 Feb; 14(1):1076-84. PubMed ID: 25730047
[TBL] [Abstract][Full Text] [Related]
17. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
Sadik NA; Ahmed A; Ahmed S
Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
19. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 promoter methylation correlation with pathogenesis of hepatocellular carcinoma in Asians.
Lu W; Liu Y; Liu LL; Zhuang PH
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
